Guanidinoacetic Acid Market Report 2025 (Global Edition)

Global Guanidinoacetic Acid Market Report 2025 Market Size Split by Type (Feed Grade, Pharmaceutical Grade, Others), by Application (Fodder, Medicines, Others)

Guanidinoacetic Acid Market Report Description

We have various report editions of Guanidinoacetic Acid Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Guanidinoacetic Acid Market

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.

 

Top Companies Market Share in Guanidinoacetic Acid Industry: (In no particular order of Rank)

• Evonik
• GENDONE
• Tiancheng Chempharm
• Lubon Industry
• Hebei Daxiao
• Shijiazhuang Zexing Group
• Hubei Yuanhua
• Jiangsu Yuanyang.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Guanidinoacetic Acid

Which Region Dominates the Guanidinoacetic Acid  Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. The guanidino acetic acid (GAA) market is expanding in North America due to rising demand from the pharmaceutical and animal feed industries. The market increase is driven by the region's focus on pharmaceutical research and cattle farming, as well as growing knowledge of the advantages of GAA. The GAA market in North America is also expanding due to investments in research & development and technical developments.

Which Region is Expanding at the Fastest CAGR?

The European region is witnessing an increase in the sales of reagents. The market for guanidino acetic acid (GAA) in Europe is growing due to increased pharmaceutical and animal feed demand. The region's emphasis on animal welfare and sustainable agriculture motivates the introduction of GAA as a feed supplement to increase cattle output. Moreover, the GAA market in Europe is expanding due to a rise in pharmaceutical application research and development.

The current report Scope analyzes Guanidinoacetic Acid Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Guanidinoacetic Acid Market Analysis

According to Cognitive Market Research, the global Guanidinoacetic Acid market size was estimated at USD 41.5 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 16.60  million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.8% from 2024 to 2031. The animal feed sector in North America is a major driver of the market's rapid expansion for guanidinoacetic acid (GAA). GAA is an important feed ingredient that improves meat quality and cattle productivity. Its capacity to enhance feed efficiency and encourage muscle growth is consistent with North America's focus on sustainable agriculture and superior animal production methods. Among these, the feed-grade category is especially noteworthy, having grown significantly as feed formulations increasingly use GAA. All things considered, the GAA market in North America is expected to grow further due to the region's robust agricultural industry and rising need for creative feed solutions to meet the demands of contemporary livestock farming.

Country Analysis

• According to Cognitive Market Research, the US had a major share in the Guanidinoacetic Acid market with a market size of USD 13.10 million in 2024 and is projected to grow at a CAGR of 2.6% during the forecast period. The demand is amplified by the nation's dynamic scientific landscape. 
• The Canada Guanidinoacetic Acid market had a market share of USD 1.99 million in 2024 and is projected to grow at a CAGR of 3.6% during the forecast period. Canada's rising biotechnology sector.
• The Mexico Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.3% during the forecast period with a market size of USD 1.51 million in 2024.

Europe Guanidinoacetic Acid Market Analysis

According to Cognitive Market Research, with a market value of USD 41.5 million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 3.1% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD 12.45  million. The dynamic agriculture and pharmaceutical sectors of Europe are driving a remarkable growth in the Guanidinoacetic Acid (GAA) industry. GAA is widely used as a feed addition in Europe, where its ability to increase cattle output fits nicely with the region's emphasis on high-quality animal nutrition and sustainable agricultural methods. Furthermore, as GAA becomes more widely acknowledged for its therapeutic potential in treating a range of neuromuscular diseases and creatine deficient syndromes, the pharmaceutical-grade industry is growing. Europe's GAA market is expected to grow further because to the feed and pharmaceutical industries' need for novel solutions, as well as increased R&D initiatives and a growing focus on animal welfare and healthcare.

• The United Kingdom Guanidinoacetic Acid market had a market share of USD 2.09 million in 2024 and is projected to grow at a CAGR of 3.9% during the forecast period. In the UK, Guanidinoacetic Acid sales witness an upswing due to the nation's robust collaborations between academia and industry. 
• The France Guanidinoacetic Acid market is projected to witness growth at a CAGR of 2.3% during the forecast period with a market size of USD 1.15 million in 2024.
• According to Cognitive Market Research, the Germany Guanidinoacetic Acid market size was valued at USD 2.47 million in 2024 and is projected to grow at a CAGR of 3.3% during the forecast period. In Germany, Guanidinoacetic Acid sales surge due to the technology. 
• The Italy Guanidinoacetic Acid market is projected to witness growth at a CAGR of 2.5% during the forecast period with a market size of USD 1.07 million in 2024.
• The Russia Guanidinoacetic Acid market is projected to witness growth at a CAGR of 2.1% during the forecast period with a market size of USD 1.93 million in 2024.
• The Spain Guanidinoacetic Acid market is projected to witness growth at a CAGR of 2.2% during the forecast period with a market size of USD 1.02 million in 2024.
• The Luxembourg Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.2% during the forecast period with a market size of USD 0.39 million in 2024.
• The Portugal Guanidinoacetic Acid market is projected to witness growth at a CAGR of 2.9% during the forecast period with a market size of USD 0.26 million in 2024.
• The Greece Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.4% during the forecast period with a market size of USD 0.15 million in 2024.
• Rest of Europe Guanidinoacetic Acid market is projected to witness growth at a CAGR of 1.8% during the forecast period with a market size of USD 1.93 million in 2024.

Asia Pacific Guanidinoacetic Acid Market Analysis

According to Cognitive Market Research, the global Guanidinoacetic Acid market size was estimated at USD 41.5 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 9.55 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031. Asia Pacific's booming pharmaceutical and agricultural sectors are driving the market for guanidinoacetic acid (GAA) to record high growth. GAA is an essential feed ingredient in this varied and quickly changing market that helps to maximize animal nutrition and output. Additionally, the pharmaceutical-grade market is growing as more research is done on the therapeutic uses of GAA, especially in treating neuromuscular diseases and creatine deficient syndromes. The GAA market is expected to grow further in Asia Pacific due to the region's expanding population and growing need for premium animal protein and healthcare products. This growth will be fueled by both agricultural innovation and medical advancements.

• According to Cognitive Market Research, the China Guanidinoacetic Acid market size was valued at USD 4.30 million in 2024 and is projected to grow at a CAGR of 6.1% during the forecast period. Guanidinoacetic Acid sales surge in China due to the nation's rapid expansion in biopharmaceuticals.
• The Japan Guanidinoacetic Acid market is projected to witness growth at a CAGR of 5.1% during the forecast period with a market size of USD 1.32 million in 2024.
• The India Guanidinoacetic Acid market had a market share of USD 1.15 million in 2024 and is projected to grow at a CAGR of 8.4% during the forecast period. The demand is augmented by India's increasing focus on precision medicine.
• The South Korea Guanidinoacetic Acid market is projected to witness growth at a CAGR of 5.7% during the forecast period with a market size of USD 0.95 million in 2024.
• The Australia Guanidinoacetic Acid market is projected to witness growth at a CAGR of 6.3% during the forecast period with a market size of USD 0.50 million in 2024.
• The South East Asia Guanidinoacetic Acid market is projected to witness growth at a CAGR of 7.6% during the forecast period with a market size of USD 0.66 million in 2024.
• The Rest of Asia Pacific Guanidinoacetic Acid market is projected to witness growth at a CAGR of 6.4% during the forecast period with a market size of USD 0.68 million in 2024.

South America Guanidinoacetic Acid Market Analysis

According to Cognitive Market Research, the global Guanidinoacetic Acid market size was estimated at USD 41.5 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 2.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031. The market for guanidinoacetic acid (GAA) is expanding significantly in Latin America thanks to the region's booming agriculture industry and growing emphasis on animal nutrition and welfare. GAA is a useful feed additive that boosts feed efficiency and promotes muscle growth in cattle production systems all throughout the region. Further study into GAA's potential therapeutic applications in treating a variety of neuromuscular diseases and muscle-related ailments has sparked interest in the pharmaceutical-grade industry. The GAA market is expected to grow in Latin America because to the region's abundant agricultural resources and growing consumer demand for premium animal products. This growth will be fueled by the feed and pharmaceutical sectors' need for cutting-edge methods to improve animal productivity and health.

• According to Cognitive Market Research, the Brazil Guanidinoacetic Acid market size was valued at USD 0.89 million in 2024 and is projected to grow at a CAGR of 4.6% during the forecast period. Guanidinoacetic Acid sales flourish in Brazil due to the nation's thriving pharmaceutical industry and increasing investments in healthcare infrastructure.
• The Argentina Guanidinoacetic Acid market had a market share of USD 0.35 million in 2024 and is projected to grow at a CAGR of 4.9% during the forecast period. The demand is augmented by Argentina's commitment to medical industry.
• The Colombia Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.8% during the forecast period with a market size of USD 0.18 million in 2024.
• The Peru Guanidinoacetic Acid market is projected to witness growth at a CAGR of 4.2% during the forecast period with a market size of USD 0.17 million in 2024.
• The Chile Guanidinoacetic Acid market is projected to witness growth at a CAGR of 4.3% during the forecast period with a market size of USD 0.15 million in 2024.
• The Rest of Latin America Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 0.33 million in 2024.

Middle East Guanidinoacetic Acid Market Analysis

According to Cognitive Market Research, the global Guanidinoacetic Acid market size was estimated at USD 41.5 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 0.83 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031. The Middle East and Africa's market for guanidinoacetic acid (GAA) is expanding steadily, helped by the region's expanding agricultural industry and rising use of contemporary cattle farming techniques. GAA is an essential feed additive that helps cattle production systems across the region grow their muscles and maximize feed efficiency. Further study on GAA's potential therapeutic applications in treating neuromuscular diseases and muscle-related ailments has sparked interest in the pharmaceutical-grade industry. The Middle East & Africa market is expected to grow due to the region's expanding population, growing demand for premium animal products, and growing knowledge of the advantages of GAA. This growth will be fueled by the need for creative solutions to enhance animal health in the agricultural and pharmaceutical sectors.

• According to Cognitive Market Research, the GCC Countries Guanidinoacetic Acid market size was valued at USD 0.36 million in 2024 and is projected to grow at a CAGR of 5.1% during the forecast period. Guanidinoacetic Acid sales flourish in the GCC Countries due to the region's strategic investments in healthcare research and advancements.
• The Egypt Guanidinoacetic Acid market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD 0.09 million in 2024.
• The South Africa Guanidinoacetic Acid market is projected to witness growth at a CAGR of 5.3% during the forecast period with a market size of USD 0.13 million in 2024. Guanidinoacetic Acid sales flourish in the South Africa due to the region's strategic investments in healthcare research and advancements.
• The Turkey Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.8% during the forecast period with a market size of USD 0.07 million in 2024.
• The Nigeria Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.4% during the forecast period with a market size of USD 0.09 million in 2024.
• The Rest of MEA Guanidinoacetic Acid market is projected to witness growth at a CAGR of 3.3% during the forecast period with a market size of USD 0.10 million in 2024.

Guanidinoacetic Acid Market Analysis

Guanidinoacetic Acid Type Segment Analysis

According to Cognitive Market Research, Feed Grade held the major market share over the forecast period. Due to its growing use as a feed additive in animal nutrition, the feed-grade segment is propelling the guanidinoacetic acid (GAA) market expansion. The feed business is experiencing increased demand for GAA due to its focus on maximizing feed efficiency, fostering muscle growth, and improving meat quality. Increasingly emphasizing high-quality and sustainable animal production methods worldwide supports this trend.

Pharmaceutical Grade is the fastest-growing category over the forecast period. The guanidinoacetic acid (GAA) market is expanding due to its potential therapeutic applications in treating neuromuscular diseases, muscular dystrophy, and creatine deficiency syndromes. The pharmaceutical-grade segment is driving this expansion. The demand for high-quality pharmaceutical-grade GAA products is being driven by growing awareness of the therapeutic benefits of GAA and increased research and development efforts in the pharmaceutical sector. This is leading to market expansion in this segment.

• Feed Grade
• Pharmaceutical Grade
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Guanidinoacetic Acid Industry. Request a Free Sample PDF!

Guanidinoacetic Acid Application Segment Analysis

According to Cognitive Market Research, Fodder holds a prominent market share. Due to its growing application as a feed additive, guanidinoacetic acid (GAA) is seeing tremendous expansion in the market thanks in large part to the fodder business. Because GAA can increase muscle growth, feed efficiency, and meat quality in cattle, it's a useful ingredient in feed formulas. The market for GAA in fodder is growing quickly in tandem with the increasing demand for superior animal nutrition.

Medicine is the fastest-growing category over the forecast period. The growing role of guanidinoacetic acid (GAA) in medicinal applications is driving the rise of the pharmaceutical-grade category. The need for high-purity pharmaceutical-grade GAA is being driven by its potential to treat neuromuscular diseases, muscular dystrophy, and creatine deficient syndromes. The market is expanding within this industry due to rising research activities and growing awareness of GAA's effectiveness in pharmaceutical formulations.

• Fodder
• Medicines
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Ashwini Moharir

Research Analyst at Cognitive Market Research

LinkedIn

Profile

Enthusiastic and analytical market research professional with 2 years of hands-on experience in tracking market trends, evaluating consumer behavior, and supporting strategic decision-making. Proficient in designing surveys, conducting interviews, and synthesizing insights from both primary and secondary sources. Successfully contributed to research projects across sectors such as retail, personal care, and industrial markets. Brings a keen eye for detail, strong data interpretation skills, and a passion for uncovering what drives markets forward. Comfortable working in fast-paced environments and collaborating across departments to deliver clear, actionable findings.

Author's Conclusion